Delivery Order SPE2DB20D3104-SPE2DB23FV4N4

Award Date 1/5/23
Potential Completion Date 1/6/23
Potential Value $5.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,763.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4,563,661 units of the HAVRIX 720 vaccine syringe (0.5 mL) to support military healthcare programs. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This is a $1,749.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies, with a completion date of January 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a $3,055.68 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.66, is for the supply of HAVRIX 720 unit/0.5 mL syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a $1,110.72 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,440 units of HAVRIX 1,440 UNIT/ML SYRINGE medication. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA...
This federal contract award, valued at $19,624.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies. The contract has a firm fixed price and is a delivery order with an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies, with a ceiling value of $8,801.76. The contract has a period of performance through February 7, 2023 and uses a Firm Fixed Price pricing type. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,842.30 for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999...
This is a $1,027.23 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for HAVRIX 1,440 UNIT/ML syringes and has an ultimate completion date of April 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV4N4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,775.30 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 720 Unit/0.5 ML Syringe 0.5ML, a pharmaceutical product, with a completion date of January 6, 2023. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:18 AM